Pulsara Around the World - August 2024
June & July Recap After exhibiting at four trade shows in June, our event schedule dropped off in July. Things will kick back into high gear again as...
1 min read
Hannah Ostrem
:
Jun 05, 2019
A recent study examined the efficacy of low-dose ketamine administered intravenously as an alternative to IV fentanyl in the prehospital environment for severe pain.
The retrospective review matched patients who received solely ketamine or fentanyl according to baseline levels of pain, on a one-to-one ratio and compared those pain levels to post-treatment pain scores. Results indicated that, compared to the group who received fentanyl IV, ketamine IV patients showed a significantly larger reduction in pain after treatment. Additionally, significantly more patients receiving the ketamine IV achieved at least a 50% reduction in pain compared to those receiving fentanyl IV (67% vs. 19%, p < 0.001).
Researchers also noted that "vital signs demonstrated a nonsignificant decrease in blood pressure, respiratory rate, heart rate, and GCS. No clinically significant adverse events were reported for patients receiving ketamine IV."
These findings add to the research indicating that ketamine could be used as an effective prehospital analgesic in place of fentanyl. What are your thoughts on replacing fentanyl with a low dose of ketamine for pain control in EMS?
June & July Recap After exhibiting at four trade shows in June, our event schedule dropped off in July. Things will kick back into high gear again as...
Brian Webster, CEO of Kestra Medical Technologies, brings significant healthcare expertise to Pulsara’s Board of Directors
At Pulsara, our customers are why we do what we do. It's our privilege to help serve the people who serve people, and we're always excited to see...